{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:18:45Z","timestamp":1788427125107,"version":"build-2803163510"},"reference-count":32,"publisher":"Walter de Gruyter GmbH","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_cclm-2026-1100_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Clinical interpretation of ferritin is hindered by between-assay differences, persisting despite the introduction of different generations of WHO standard. To aid harmonisation efforts, this study investigates the commutability of External Quality Assessment (EQA) materials, proof-of-concept reference materials (cRMs), and the newest generation of WHO standard (19\/118).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-1100_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Four multi-level serum-based cRMs, 50 clinical samples, four EQA materials, and WHO 19\/118 were measured with Abbott Alinity, Beckman Coulter Access DxI, Roche Cobas and Siemens Atellica. Commutability was analysed using the prediction interval approach for EQA materials and the difference in bias and calibration effectiveness approaches for cRMs and WHO standard.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-1100_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Differences in assay selectivity did not allow for formal commutability assessment of EQA materials. Nevertheless, all four investigated EQA materials fell within the 95\u202f% prediction interval around clinical samples in all six method comparisons, indicating their suitability for monitoring harmonisation status. Calibration effectiveness demonstrated commutability for cRM1 and cRM3, in contrast to poor commutability for cRM2, cRM4 and WHO 19\/118. Recalibration with cRM1 decreased inter-assay CV four-fold from 34\u202f% to 8.2\u202f%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-1100_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Improving harmonisation among current ferritin assays is possible, and success of such efforts can be monitored with EQA materials. Although limited by differences in selectivity, the harmonisation potential of the current assays is substantial, and therefore we encourage harmonisation based on a ISO15194-proof material produced like our cRM1 or cRM3. True standardisation will need much more time, requiring prior measurand characterisation, identification of a clinically relevant ferritin measurand, and subsequent assay redesign to eliminate differences in selectivity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/cclm-2026-1100","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:56:23Z","timestamp":1788425783000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluating feasibility of ferritin assay harmonisation with commutable proof-of-concept reference materials and EQA-based monitoring"],"prefix":"10.1515","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7717-252X","authenticated-orcid":false,"given":"Moniek M.","family":"Bioch","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine , Radboud University Medical Center , Nijmegen , the Netherlands"},{"name":"SKML Foundation for Quality Assessment in Medical Laboratory Diagnostics , Nijmegen , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier M.","family":"Schoeman","sequence":"additional","affiliation":[{"name":"MCA Laboratory, Queen Beatrix Hospital , Winterswijk , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cas W.","family":"Weykamp","sequence":"additional","affiliation":[{"name":"MCA Laboratory, Queen Beatrix Hospital , Winterswijk , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"van der Vuurst","sequence":"additional","affiliation":[{"name":"Clinical Chemistry and Haematology Laboratory, Queen Beatrix Hospital , Winterswijk , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldy W.H.M.","family":"Kuypers","sequence":"additional","affiliation":[{"name":"Clinical Chemistry Laboratory, Pantein Hospital , Beugen , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fokke A.","family":"Lindeboom","sequence":"additional","affiliation":[{"name":"Clinical Chemistry Laboratory & Thrombosis Service, Franciscus Vlietland , Schiedam , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke A.M.","family":"Frasa","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Chemistry and Haematology, Jeroen Bosch Hospital , s-Hertogenbosch , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonius E.","family":"van Herwaarden","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , Radboud University Medical Center , Nijmegen , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorine W.","family":"Swinkels","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , Radboud University Medical Center , Nijmegen , the Netherlands"},{"name":"Sanquin Blood Bank , Amsterdam , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1771-669X","authenticated-orcid":false,"given":"Marc H.M.","family":"Thelen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , Radboud University Medical Center , Nijmegen , the Netherlands"},{"name":"SKML Foundation for Quality Assessment in Medical Laboratory Diagnostics , Nijmegen , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"2026090308554032484_j_cclm-2026-1100_ref_001","unstructured":"Swinkels, DW. Chapter 40: iron metabolism. In: Rifai, N, Chiu, RWK, Young, I, Burnham, CAD, Wittwer, CT, editors. Tietz textbook of clinical chemistry and molecular diagnostics, 7th ed. St Louis, MO: Elsevier Saunders; 2023."},{"key":"2026090308554032484_j_cclm-2026-1100_ref_002","doi-asserted-by":"crossref","unstructured":"International Committee for Standardization in Hematology (ICSH). Proposed international standard of human ferritin for the serum ferritin assay. Br J Haematol 1985;61:61\u20133.","DOI":"10.1111\/j.1365-2141.1985.tb04060.x"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_003","doi-asserted-by":"crossref","unstructured":"Thorpe, SJ, Walker, D, Arosio, P, Heath, A, Cook, JD, Worwood, M. International collaborative study to evaluate a recombinant L ferritin preparation as an international standard. Clin Chem 1997;43:1582\u20137. https:\/\/doi.org\/10.1093\/clinchem\/43.9.1582.","DOI":"10.1093\/clinchem\/43.9.1582"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_004","doi-asserted-by":"crossref","unstructured":"Blackmore, S, Hamilton, M, Lee, A, Worwood, M, Brierley, M, Heath, A, et al.. Automated immunoassay methods for ferritin: recovery studies to assess traceability to an international standard. Clin Chem Lab Med 2008;46:1450\u20137. https:\/\/doi.org\/10.1515\/cclm.2008.304.","DOI":"10.1515\/CCLM.2008.304"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_005","doi-asserted-by":"crossref","unstructured":"Fox, B, Roberts, G, Atkinson, E, Rigsby, P, Ball, C. International collaborative study to evaluate and calibrate two recombinant L chain ferritin preparations for use as a WHO international standard. Clin Chem Lab Med 2022;60:370\u20138. https:\/\/doi.org\/10.1515\/cclm-2021-1139.","DOI":"10.1515\/cclm-2021-1139"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_006","doi-asserted-by":"crossref","unstructured":"Swinkels, DW, Van Schrojenstein Lantman, M, Matlung, HL, Weykamp, C, Thelen, M. Equivalence in clinical assessment of iron status requires ferritin assay standardization before harmonization of ferritin reference intervals. Lancet Haematol 2024;11:e721. https:\/\/doi.org\/10.1016\/s2352-3026(24)00245-x.","DOI":"10.1016\/S2352-3026(24)00245-X"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_007","doi-asserted-by":"crossref","unstructured":"Braga, F, Pasqualetti, S, Frusciante, E, Borrillo, F, Chibireva, M, Panteghini, M. Harmonization status of serum ferritin measurements and implications for use as marker of iron-related disorders. Clin Chem 2022;68:1202\u201310. https:\/\/doi.org\/10.1093\/clinchem\/hvac099.","DOI":"10.1093\/clinchem\/hvac099"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_008","doi-asserted-by":"crossref","unstructured":"Choy, KW, Sezgin, G, Wijeratne, N, Calleja, J, Liwayan, R, Rathnayake, G, et al.. Assessment of analytical bias in ferritin assays and impact on functional reference limits. Pathol 2022;54:302\u20137. https:\/\/doi.org\/10.1016\/j.pathol.2021.06.123.","DOI":"10.1016\/j.pathol.2021.06.123"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_009","doi-asserted-by":"crossref","unstructured":"Rovegno, L, Civera, E, Infusino, I, Panteghini, M. State of the art of measurement uncertainty of serum ferritin. Clin Chem Lab Med 2024;62:e6\u20138. https:\/\/doi.org\/10.1515\/cclm-2023-0711.","DOI":"10.1515\/cclm-2023-0711"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_010","doi-asserted-by":"crossref","unstructured":"Kurstjens, S, Van Dam, AD, Oortwijn, E, Den Elzen, WPJ, Candido, F, Kusters, R, et al.. Inconsistency in ferritin reference intervals across laboratories: a major concern for clinical decision making. Clin Chem Lab Med 2025;63:600\u201310. https:\/\/doi.org\/10.1515\/cclm-2024-0826.","DOI":"10.1515\/cclm-2024-0826"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_011","doi-asserted-by":"crossref","unstructured":"van Schrojenstein Lantman, M, van Berkel, M, Kuijper, P, Langelaan, M, Brouwer, N, Thelen, M. Clinical decision-making suffers from inequivalent measurement results and inadequate reference intervals. Clin Chem 2024;70:1383\u201392. https:\/\/doi.org\/10.1093\/clinchem\/hvae129.","DOI":"10.1093\/clinchem\/hvae129"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_012","doi-asserted-by":"crossref","unstructured":"Plebani, M, Lippi, G. Standardization and harmonization in laboratory medicine: not only for clinical chemistry measurands. Clin Chem Lab Med 2023;61:185\u20137. https:\/\/doi.org\/10.1515\/cclm-2022-1122.","DOI":"10.1515\/cclm-2022-1122"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_013","unstructured":"SKML. Hormones in serum. www.skml.nl\/en\/schemes\/204\/ [Accessed Jun 2026]."},{"key":"2026090308554032484_j_cclm-2026-1100_ref_014","doi-asserted-by":"crossref","unstructured":"Sacri, A-S, Ferreira, D, Khoshnood, B, Gouya, L, Barros, H, Chalumeau, M. Stability of serum ferritin measured by immunoturbidimetric assay after storage at -80\u00b0C for several years. PLoS One 2017;12:e0188332. https:\/\/doi.org\/10.1371\/journal.pone.0188332.","DOI":"10.1371\/journal.pone.0188332"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_015","doi-asserted-by":"crossref","unstructured":"Lemaire, B, Frias, MA, Golaz, O, Magnin, J-L, Viette, V, Vuilleumier, N, et al.. Ferritin: a biomarker requiring caution in clinical decision. Diagn 2024;14:386. https:\/\/doi.org\/10.3390\/diagnostics14040386.","DOI":"10.3390\/diagnostics14040386"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_016","doi-asserted-by":"crossref","unstructured":"Sandberg, S, Fauskanger, P, Johansen, JV, Keller, T, Budd, J, Greenberg, N, et al.. Recommendations for setting a criterion and assessing commutability of sample materials used in external quality assessment\/proficiency testing schemes. Clin Chem 2023;69:1227\u201337. https:\/\/doi.org\/10.1093\/clinchem\/hvad135.","DOI":"10.1093\/clinchem\/hvad135"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_017","doi-asserted-by":"crossref","unstructured":"Nilsson, G, Budd, JR, Greenberg, N, Delatour, V, Rej, R, Panteghini, M, et al.. IFCC working group recommendations for assessing commutability part 2: using the difference in bias between a reference material and clinical samples. Clin Chem 2018;64:455\u201364. https:\/\/doi.org\/10.1373\/clinchem.2017.277541.","DOI":"10.1373\/clinchem.2017.277541"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_018","doi-asserted-by":"crossref","unstructured":"Budd, JR, Weykamp, C, Rej, R, MacKenzie, F, Ceriotti, F, Greenberg, N, et al.. IFCC working group recommendations for assessing commutability part 3: using the calibration effectiveness of a reference material. Clin Chem 2018;64:465\u201374. https:\/\/doi.org\/10.1373\/clinchem.2017.277558.","DOI":"10.1373\/clinchem.2017.277558"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_019","doi-asserted-by":"crossref","unstructured":"Miller, WG, Schimmel, H, Rej, R, Greenberg, N, Ceriotti, F, Burns, C, et al.. IFCC working group recommendations for assessing commutability part 1: general experimental design. Clin Chem 2018;64:447\u201354. https:\/\/doi.org\/10.1373\/clinchem.2017.277525.","DOI":"10.1373\/clinchem.2017.277525"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_020","doi-asserted-by":"crossref","unstructured":"Miller, WG, Keller, T, Budd, J, Johansen, JV, Panteghini, M, Greenberg, N, et al.. Recommendations for setting a criterion for assessing commutability of secondary calibrator certified reference materials. Clin Chem 2023;69:966\u201375. https:\/\/doi.org\/10.1093\/clinchem\/hvad104.","DOI":"10.1093\/clinchem\/hvad104"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_022","unstructured":"Sandberg, S, Fauskanger, P, Johansen, J, Keller, T, Budd, J, Greenberg, N, et al.. Commutability assessment of external quality assessment materials. www.noklus.no\/en\/a-practical-tool-for-commutability-evaluation-of-external-quality-assessment-material [Accessed January 2026]."},{"key":"2026090308554032484_j_cclm-2026-1100_ref_021","doi-asserted-by":"crossref","unstructured":"Fauskanger, PK, Sandberg, S, Johansen, J, Keller, T, Budd, J, Miller, WG, et al.. Quantification of difference in nonselectivity between in\u00a0vitro diagnostic medical devices. Biom J 2025;67:e70032. https:\/\/doi.org\/10.1002\/bimj.70032.","DOI":"10.1002\/bimj.70032"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_023","unstructured":"CLSI. Characterization and qualification of commutable reference materials for laboratory medicine, 2nd ed. CLSI guideline EP30. Clinical and Laboratory Standards Institute; 2024."},{"key":"2026090308554032484_j_cclm-2026-1100_ref_024","doi-asserted-by":"crossref","unstructured":"Asare-Werehene, M, Shao, QY, Leung, F, Brinc, D, Ren, A, Kavsak, PA, et al.. Hook effect for ferritin immunoassays: implications for clinical practice. Clin Chem Lab Med 2026;64:e113\u20137. https:\/\/doi.org\/10.1515\/cclm-2025-1277.","DOI":"10.1515\/cclm-2025-1277"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_025","doi-asserted-by":"crossref","unstructured":"Hazard, J, Yokota, M, Arosio, P, Drysdale, J. Immunologic differences in human isoferritins: implications for immunologic quantitation of serum ferritin. Blood 1977;49:139\u201346. https:\/\/doi.org\/10.1182\/blood.v49.1.139.bloodjournal491139.","DOI":"10.1182\/blood.V49.1.139.bloodjournal491139"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_026","doi-asserted-by":"crossref","unstructured":"Kotla, NK, Dutta, P, Parimi, S, Das, NK. The role of ferritin in health and disease: recent advances and understandings. Metabolites 2022;12:609. https:\/\/doi.org\/10.3390\/metabo12070609.","DOI":"10.3390\/metabo12070609"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_027","doi-asserted-by":"crossref","unstructured":"Crichton, RR, Declercq, J-P. X-ray structures of ferritins and related proteins. Biochim Biophys Acta Gen Subj 2010;1800:706\u201318. https:\/\/doi.org\/10.1016\/j.bbagen.2010.03.019.","DOI":"10.1016\/j.bbagen.2010.03.019"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_028","doi-asserted-by":"crossref","unstructured":"Koorts, AM, Viljoen, M. Ferritin and ferritin isoforms I: structure\u2013function relationships, synthesis, degradation and secretion. Arch Physiol Biochem 2007;113:30\u201354. https:\/\/doi.org\/10.1080\/13813450701318583.","DOI":"10.1080\/13813450701318583"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_029","doi-asserted-by":"crossref","unstructured":"Plays, M, M\u00fcller, S, Rodriguez, R. Chemistry and biology of ferritin. Metallomics 2021;13:mfab021. https:\/\/doi.org\/10.1093\/mtomcs\/mfab021.","DOI":"10.1093\/mtomcs\/mfab021"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_030","doi-asserted-by":"crossref","unstructured":"Ghosh, S, Hevi, S, Chuck, SL. Regulated secretion of glycosylated human ferritin from hepatocytes. Blood 2004;103:2369\u201376. https:\/\/doi.org\/10.1182\/blood-2003-09-3050.","DOI":"10.1182\/blood-2003-09-3050"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_031","doi-asserted-by":"crossref","unstructured":"Koorts, AM, Viljoen, M. Ferritin and ferritin isoforms II: protection against uncontrolled cellular proliferation, oxidative damage and inflammatory processes. Arch Physiol Biochem 2007;113:55\u201364.","DOI":"10.1080\/13813450701422575"},{"key":"2026090308554032484_j_cclm-2026-1100_ref_032","doi-asserted-by":"crossref","unstructured":"Ishihara, A, Yamauchi, T, Ikeda, K, Fukuyoshi, Y, Yokoyama, T, Yonemura, Y, et al.. Glycosylated ferritin as an improved marker for post-transfusion iron overload. Int J Hematol 2021;113:537\u201346. https:\/\/doi.org\/10.1007\/s12185-020-03056-9.","DOI":"10.1007\/s12185-020-03056-9"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1100\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1100\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:56:26Z","timestamp":1788425786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1100\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":32,"alternative-id":["10.1515\/cclm-2026-1100"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2026-1100","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]}}}